Cargando…
Cell‐free DNA as a biomarker after lung transplantation: A proof‐of‐concept study
BACKGROUND: Lung transplantation (LTx) is a lifesaving procedure burdened with limited long‐term survival. The most common cause of death after LTx is chronic lung allograft dysfunction (CLAD). Today, useful biomarkers for the detection of CLAD are lacking. Circulating cell‐free DNA (cfDNA) is relea...
Autores principales: | Magnusson, Jesper M., Ricksten, Anne, Dellgren, Göran, Wasslavik, Carina, Nordén, Rickard, Westin, Johan, Boehmer, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017613/ https://www.ncbi.nlm.nih.gov/pubmed/35478446 http://dx.doi.org/10.1002/iid3.620 |
Ejemplares similares
-
Absolute Quantification of Donor-Derived Cell-Free DNA in Pediatric and Adult Patients After Heart Transplantation: A Prospective Study
por: Böhmer, Jens, et al.
Publicado: (2023) -
COMP: A Potential Early Biomarker of RAS After Lung Transplantation
por: Novo, Mirza, et al.
Publicado: (2021) -
Viral Respiratory Tract Infection During the First Postoperative Year Is a Risk Factor for Chronic Rejection After Lung Transplantation
por: Magnusson, Jesper, et al.
Publicado: (2018) -
Quantification of Torque Teno Virus and Epstein-Barr Virus Is of Limited Value for Predicting the Net State of Immunosuppression After Lung Transplantation
por: Nordén, Rickard, et al.
Publicado: (2018) -
Extended use of extra corporeal membrane oxygenation as bridge to lung transplantation in two patients
por: Skansebo, Elin, et al.
Publicado: (2020)